Clinical decision support, not a device.

AEGIS is designed and configured to operate as clinical decision support rather than Software as a Medical Device. It organises reported results and established risk factors for a licensed clinician, and that clinician can independently review the basis of every recommendation rather than relying on an opaque output. Confirm the current regulatory position with the AEGIS team.

Your practice physician reviews each profile and signs the plan as reviewer of record. An AEGIS clinician also reviews each profile before it reaches you, as a second check. That is how the service runs today. Your practice licenses AEGIS, so this is not a referral. Confirm how liability is allocated with your own counsel and carrier.

No. AEGIS synthesizes risk and surfaces options. Where a recommendation involves a third-party test, AEGIS stays within that test's manufacturer labeling and makes no claims beyond it.

Yes, by design. Every recommendation traces back to its source inputs and is independently reviewable, with an audit trail of clinician review and sign-off behind it.

Your physician stays the reviewer of record, with an AEGIS clinician review as a second check. Plans are kept to low-harm, guideline-concordant prevention that never replaces screening or usual care, and every recommendation is tied to its evidence in the record. Elective tests a clinician may additionally order, such as whole-body MRI or a multi-cancer early detection blood test, are not guideline-recommended screening for asymptomatic adults and sit outside the signed prevention plan; who pays for them is set out under Billing and licence. Confirm the specifics with your own counsel and carrier.